Skip to main content

Day: September 23, 2024

Antibiotics Market to Exceed Market Valuation of USD 72.65 Billion by 2031 | SkyQuest Technology

Antibiotics Market size was valued at USD 52.67 billion in 2023 to USD 72.65 billion by 2031, growing at a CAGR of 4.10% during the forecast period (2024-2031). Westford, USA, Sept. 23, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the Global Antibiotics Market will reach a value of USD 72.65 Billion by 2031, with a CAGR of 4.10% during the forecast period (2024-2031). Antibiotics are the major parts of the pharmaceutical industry, impacted by the rising need to treat several bacterial infections. It comprises products, such as cephalosporins, penicillins, and macrolides. In recent years, there has been a growing interest in developing alternate and novel antibiotics to fight resistant strains. Moreover, the growing elderly population and increasing cases of infections are the key factors driving the growth of the antibiotics...

Continue reading

38/2024・Trifork Group AG – Financial Calendar 2025

Company announcement no. 38 / 2024 Schindellegi, Switzerland – 23 September 2024 Trifork Group – Financial Calendar 2025 Trifork today publishes its financial calendar for 2025.Q4 and Annual Report 2024 28 February 2025Annual General Meeting 2025 15 April 2025Q1 Report 2025 6 May 2025Q2 & Half-Year Report 2025 19 August 2025Q3 Report 2025 31 October 2025ContactFrederik Svanholm, Group Investment Director & Head of IRfrsv@trifork.com, +41 79 357 7317 About Trifork Group  Trifork is a globally pioneering technology partner to its enterprise and public sector customers. The group has 1,273 employees across 74 business units in 15 countries. Trifork works in six business areas: Digital Health, FinTech, Smart Building, Smart Enterprise, Cloud Operations, and Cyber Protection. Trifork’s research and development takes place...

Continue reading

Crown PE Pipelines Division Secures Two Contracts for Lead Pipe Remediation Totaling $33 Million

LOS ANGELES, Sept. 23, 2024 (GLOBE NEWSWIRE) — Crown Electrokinetics Corp. (NASDAQ: CRKN) (“Crown” or the “Company”), a leading smart glass technology company and an expert in constructing fiber optic networks and lead pipe inspection and remediation, today announced that its PE Pipelines division has secured two contracts valued at $33 million for lead pipe remediation. The work is scheduled to begin in January 2025. “These two contracts represent our first project in lead pipe remediation and the first project in PE Pipelines,” says David Kinsella, President of PE Pipelines. “Opportunities like this continue to further Crown’s mission to help transform infrastructure to improve people’s lives. Lead in drinking water pipes represents an enormous problem for the United States of America and we are proud to be playing a key...

Continue reading

Innofactor Plc: Managers’ Transactions

Innofactor Plc Managers’ Transactions, on September 23, 2024, at 16:30 Finnish time  Innofactor Oyj – Managers’ Transactions ____________________________________________ Person subject to the notification requirementName: Kaija LinturiPosition: Closely associated person (1):Person Discharging Managerial Responsibilities In IssuerName: Risto LinturiPosition: Member of the Board Issuer: Innofactor OyjLEI: 7437008OSKQFEDZYD835Notification type: INITIAL NOTIFICATIONReference number: 78208/4/4 ____________________________________________ Transaction date: 2024-09-19Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009007637Nature of transaction: DISPOSAL Transaction details(1): Volume: 430000 Unit price: 1.68 EUR Aggregated transactions (1):Volume: 430000 Volume weighted average price: 1.68 EUR Espoo, September...

Continue reading

Innofactor Plc: Managers’ Transactions

Innofactor Plc Managers’ Transactions, on September 23, 2024, at 16:30 Finnish time Innofactor Oyj – Managers’ Transactions ____________________________________________ Person subject to the notification requirementName: R. Linturi OyjPosition: Closely associated person(X) Legal person (1):Person Discharging Managerial Responsibilities In IssuerName: Risto LinturiPosition: Member of the Board Issuer: Innofactor OyjLEI: 7437008OSKQFEDZYD835Notification type: INITIAL NOTIFICATIONReference number: 78198/4/4 ____________________________________________ Transaction date: 2024-09-19Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009007637Nature of transaction: DISPOSAL Transaction details(1): Volume: 489107 Unit price: 1.68 EUR Aggregated transactions (1):Volume: 489107 Volume weighted average price: 1.68 EUR Espoo,...

Continue reading

Innofactor Plc: Managers’ Transactions – Risto Linturi

Innofactor Plc Managers’ Transactions, on September 23, 2024, at 16:25 Finnish time Innofactor Oyj – Managers’ Transactions ____________________________________________ Person subject to the notification requirementName: Risto LinturiPosition: Member of the Board/Deputy memberIssuer: Innofactor OyjLEI: 7437008OSKQFEDZYD835Notification type: INITIAL NOTIFICATIONReference number: 78187/4/4 ____________________________________________ Transaction date: 2024-09-19Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN: FI0009007637Nature of transaction: DISPOSAL Transaction details(1): Volume: 337304 Unit price: 1.68 EUR Aggregated transactions (1):Volume: 337304 Volume weighted average price: 1.68 EUR Espoo, September 23, 2024 INNOFACTOR PLC Eija Theis, General Counsel Additional information:Eija Theis, General CounselInnofactor...

Continue reading

Capricor Therapeutics to Provide Duchenne Muscular Dystrophy Program Update on September 24, 2024

Investor Webcast on Tuesday, September 24, 2024 at 8:30 a.m. ET SAN DIEGO, Sept. 23, 2024 (GLOBE NEWSWIRE) — Capricor Therapeutics (NASDAQ: CAPR), a biotechnology company developing transformative cell and exosome-based therapeutics for the treatment of rare diseases, today announced that it will host an investor webcast on Tuesday, September 24, 2024 at 8:30 a.m. ET to provide an update on its Duchenne muscular dystrophy (DMD) program. The update will consist of the latest regulatory updates following the Company’s recent meetings with the U.S. Food and Drug Administration (FDA). Webcast Details Capricor will host a conference call and webcast at 8:30 a.m. ET on Tuesday, September 24, 2024. To participate in the conference call, please dial 1-800-717-1738 (domestic/toll-free) or 1-646-307-1865 (international) and reference the...

Continue reading

REE Automotive Kick-Off U.S. Production With Roush Industries as Contract Manufacturer

Production of P7 electric truck line-up to begin Q4 2024 at Roush’s facility in Detroit, Michigan, with annual capacity of up to 5,000 trucks. Motherson to manage global supply chain and logistics for U.S. production as well as on-site manufacturing and quality assurance support via Motherson SAS in Detroit. Faster production ramp up, improved unit costs, and accelerated road to free-cash flow generation are expected. Customers have begun securing production slots.TEL AVIV, Israel, Sept. 23, 2024 (GLOBE NEWSWIRE) — Marking a significant milestone on its path to electrifying fleet vehicles across North America, REE Automotive Ltd. (Nasdaq: REE), an automotive technology company and provider of full by-wire electric trucks and platforms, today announced that it has selected Roush Industries, a leading innovative vehicle contract...

Continue reading

Partners Value Split Corp. Announces $125,000,000 Public Offering of Class AA Preferred Shares, Series 14

NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. WIRE SERVICES TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) — Partners Value Split Corp. (the “Company”) announced today that it has entered into an agreement to sell 5,000,000 Class AA Preferred Shares, Series 14 (the “Series 14 Preferred Shares”) to a syndicate of underwriters led by Scotiabank, BMO Capital Markets, CIBC Capital Markets, RBC Capital Markets and TD Securities Inc. on a bought deal basis. The Series 14 Preferred Shares will be issued at a price of $25.00 per share, for gross proceeds of $125,000,000. The Series 14 Preferred Shares will carry a fixed coupon of 5.50% and will have a final maturity of June 30, 2030. The Series 14 Preferred Shares have a provisional rating of Pfd-2 from DBRS Limited. The net proceeds of the offering will...

Continue reading

SAIHEAT Strengthens its Leadership Position in the Middle Eastern Nuclear and SMR Markets with Two Memorandums of Understanding (MoU)

SINGAPORE, Sept. 23, 2024 (GLOBE NEWSWIRE) — SAIHEAT Limited (f/k/a SAI.TECH Global Corporation) (“SAIHEAT” or the “Company”) (NASDAQ: SAIH, SAITW), announces the signing of two Memorandums of Understanding (MoU) for its HEATNUC business line. These agreements aim to strengthen cooperation within the small modular reactor industry in the Middle East and globally. These memorandums of understanding aim to enhance SAI.TECH’s competitiveness in the Middle Eastern and global markets, and further promote its localization strategy in the region. The MoU signed with Jiangsu Shentong Nuclear Equipment Co., Ltd., signifies a strategic partnership focused on the export of electrical and instrumentation control system equipment for nuclear power and engineering projects. This includes butterfly valves, ball valves, check valves, instrument...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.